1. Technical Field
The present disclosure relates to an access assembly for use in minimally invasive surgical procedures, such as endoscopic or laparoscopic-type procedures, and more particularly to an access assembly with a surgical access port with an adapter.
2. Background of Related Art
Today, many surgical procedures are performed through small incisions in the skin, as compared to the larger incisions typically required in traditional procedures, in an effort to reduce both trauma to the patient and recovery time. Generally, such procedures are referred to as endoscopic, unless performed on the patient's abdomen, in which case the procedure is referred to as laparoscopic. Throughout the present disclosure, the term minimally invasive should be understood to encompass both endoscopic and laparoscopic procedures. During a typical minimally invasive procedure, surgical objects, such as surgical access ports (e.g., trocar and/or cannula assemblies), endoscopes, or other instruments, are inserted into the patient's body through the incision in tissue. Prior to the introduction of the surgical object into the patient's body, insufflation gases may be used to enlarge the area surrounding the target surgical site to create a larger, more accessible work area. Accordingly, the maintenance of a substantially fluid-tight seal is desirable so as to minimize the escape of insufflation gases and the deflation or collapse of the enlarged surgical site.
To this end, various access members are used during the course of minimally invasive procedures and are widely known in the art. A continuing need exists for an access member of a universal size that can be inserted into a variety of tissue incision sites and maintain the conditions of the insufflated surgical site. It is desirable to accommodate a variety of tissue incisions and body surface conditions, and adapt to changing conditions at the surgery site.
In accordance with various embodiments, the present disclosure is directed toward a surgical access assembly with an access port and an adapter, both of which in various embodiments maybe formed of a resiliently compressible material, e.g., foam, to sealably fit in a surgical site.
An access port defines a longitudinal axis and has proximal and distal ends. The ends of the surgical access port are defined by a pair of flanges. Disposed through the access port along a path substantially parallel to the longitudinal axis is at least one lumen.
An adapter receives the surgical access port, the adapter having proximal and distal ends. The adapter has a diameter at its distal end that is different from the surgical access port. The adapter has a flange on at least its distal end, and contains an internal recess near the distal end to receive the flange at the distal end of the access port. The adapter has at least one exit aperture in its distal end to allow objects to exit the at least one lumen in the access port.
In another embodiment, the adapter also has a flange on its proximal end, with an internal recess disposed near the proximal end for receiving the flange at the proximal end of the access port. Thus, the surgical access port is disposed entirely within the adapter.
In a further embodiment, the adapter has no flanges at its ends, and is disposed on the outer surface of the access port between the flanges at the ends of the access port. Also present is a tissue engaging member having proximal end and a distal end that engage a body surface and an internal tissue wall. The proximal end and distal end of the tissue engaging member are defined by rings that may contain a rigid or resilient element for rolling portions of the tissue engaging member so as to shorten its length.
In another embodiment of the surgical access assembly, the proximal end of the adapter is rolled away from the access port and down toward a body surface. Thus, the axial length of the adapter may be changed. The rolled end of the adapter may also act as a flange, giving an operator control over the size of the flange.
In still another embodiment of the surgical access assembly, the adapter contains a gap in its outer circumference, and the gap is biased to a closed position when an access port is inserted into the adapter.
Also disclosed is a method of placing a surgical access assembly in a surgical site. The operator will select a surgical access port, and insert the surgical access port into an adapter. A tissue engaging member may also be present at the surgical site, and can be inserted before or in conjunction with the access port and adapter. Surgical instruments may be inserted through the lumens in the surgical access port to an internal body cavity below, and a minimally invasive procedure may be performed. Surgical instruments may then be removed from the at least one lumen, and the surgical access assembly can be removed from the surgical site.
The various aspects of this disclosure will be more readily understood from the following detailed description when read in conjunction with the appended drawings.
The present disclosure will now describe in detail embodiments of a surgical access assembly with reference to the drawings in which like reference numerals designate identical or substantially similar parts in each view. Throughout the description, the term “proximal” will refer to the portion of the assembly closest to the operator, whereas the term “distal” will refer to the portion of the assembly farthest from the operator. Although discussed in terms of an incision for a minimally invasive procedure, the presently disclosed surgical access assembly may be used in any naturally occurring orifice (e.g. mouth, anus, or vagina).
Referring initially to
Extending through the access port 110 along the longitudinal axis A1 is at least one lumen 120, and in embodiments, multiple lumens 120. The lumens 120 have entrance apertures 120a and exit apertures 120b and are disposed substantially parallel to the longitudinal axis A1. Lumens 120 provide a path for objects such as surgical instruments to be inserted through the surgical access assembly 100. Lumens 120 may also provide a path for insufflation fluids to be introduced to an internal body cavity 600b below surgical access assembly 100. An access port of the type generally described above is disclosed in U.S. Patent Application Publication Nos. 2009/0093752 A1 and 2010/0240960 A1, the entire disclosures of which are incorporated by reference herein.
Disposed on an outer surface of the access port 110 is an adapter 130. Adapter 130 has a proximal end 130a and a distal end 130b, and a passage therethrough for the receipt of access port 110. A flange 132b may be present at the distal end 130b of adapter 130. In other embodiments, no flange may be present on adapter 130. A flange 132b at a distal end 130b of adapter 130 may define an internal recess 134b that receives flange 112b at the distal end 110b of access port 110. The engagement of the flange 112b at the distal end 110b of the access port 110 with the internal recess 134b near the distal end 130b of the adapter 130 may serve to anchor the access port 110 to the adapter 130.
Adapter 130 has an inner diameter sized to accommodate a range of access ports. The outer diameter of adapter 130 may be varied so as to sealably engage a layer of tissue 600 of different sizes and configurations. A substantially fluid-tight seal is formed between the inner diameter of adapter 130 and the outer diameter of access port 110. The substantially fluid-tight seal minimizes the escape of insufflation gases from an internal body cavity 600 below surgical access assembly 100.
Adapter 130 and access port 110 may be formed as one single unit, or may be separable, with the access port 110 inserted into adapter 130 before or during use. Access port 110 may also be removed from adapter 130 and replaced with another access member or another object. The outer surface of access port 110 and the inner surface of adapter 130 may frictionally engage upon insertion, or may be provided with a lubricous surface treatment so as to ease insertion.
Turning now to
Referring to
Similarly referring to
Turning now to
In use, the operator of the surgical access assembly 100 will insert access port 110 into adapter 130, and dispose the surgical access assembly 100 in a layer of tissue 600. Alternatively, access port 110 may be pre-assembled with adapter 130. Surgical instruments 700 can then be inserted into surgical access port 110 and minimally invasive procedures can be performed. While disposed in a layer of tissue 600, access port 110 may be removed from adapter 130 and replaced with another access member. When a minimally invasive procedure is completed, surgical instruments 700 can be removed from surgical access assembly 100 and the surgical access assembly 100 can then be removed from the layer of tissue 600.
Referring to
Surgical access assembly 200 also contains adapter 230 having a proximal end 230a and a distal end 230b. Adapter 230 is sized to sealably engage access port 110 to minimize the escape of insufflation gases from the internal body cavity 600b below surgical access assembly 200. Adapter 230 includes a flange 232a at the proximal end 230, and a flange 232b at the distal end 230b. An internal recess 234a is present at the proximal end 230a of the adapter 230, and an internal recess 234b is present at the distal end 230b of the adapter 230. Internal recesses 234a, 234b engage flanges 112a, 112b at the proximal end 110a and distal end 110b of access port 110, respectively. Thus, access port 110 is anchored to adapter 230 as it is disposed entirely within adapter 230. Adapter 230 has lumen entrance apertures 120a′ and lumen exit apertures 120b′ to allow objects to pass through surgical access assembly 200 unobstructed.
Accordingly, surgical instruments 700 are shown inserted through surgical access assembly 200 and into internal body cavity 600b. End effectors 700b of surgical instruments 700 can be manipulated from a point proximal of surgical access assembly 200 to perform desired tasks on an internal body cavity 600b.
Turning now to
Surgical access assembly 300 also includes an adapter 330. Adapter 330 has a proximal end 330a and a distal end 330b and includes a passage therethrough for receiving access port 110. The inner diameter of adapter sealably engages access port 110 to minimize the escape of insufflation gases from an internal body cavity 600b. The outer diameter of adapter 330 may vary to accommodate a variety of incision sites and tissue layer geometries.
Adapter 330 may extend beyond proximal end 110a or distal end 110b of access port 110 and may include flanges at its proximal end 330a and distal end 330b as in adapters 130, 230 discussed above, or may have an axial length less than access port 110, as shown. In this instance, the adapter 330 is disposed between the flanges 112a, 112b at the proximal end 110a and distal end 110b of the access port 110.
Also included in surgical access assembly 300 is a tissue engaging member 140 having a proximal end 140a and a distal end 140b. Tissue engaging member 140 is disposed around the perimeter of an incision site in a layer of tissue. Tissue engaging member 140 covers a portion of body surface 600a, extends into tissue layer 600, and onto an internal tissue wall 600c. Distal end 140b of tissue engaging member 140 is defined by a ring that contacts internal tissue wall 600c. The ring at the distal end 140b of tissue engaging member may be formed simply by rolling the edge of tissue engaging member 140, or may contain a rigid or resilient ring-like element over which tissue engaging member 140 is rolled. Proximal end 140a of tissue engaging member 140 is also defined by a ring and contacts body surface 600a. Proximal end 140a of tissue engaging member 140 generally contains a rigid or resilient arcuate element 142 over which tissue engaging member 140 is rolled. The arcuate or kidney bean shape of the arcuate element 142 inhibits the tissue engaging member from unrolling at the proximal end 140a. Other shapes are contemplated as a rigid or resilient rolling member at the proximal end 140a of the tissue engaging member 140. Thus, an operator may shorten the length of tissue engaging member 140 between the proximal end 140a and distal end 140b. Rolling the proximal end 140a of tissue engaging member 140 also exerts force on a layer of tissue 600 such that it may retract tissue.
Tissue engaging member 140 engages the outer surface of adapter 330, and protects tissue layer 600 from damage caused by frictional engagement, shifting during operation, or other harmful forces caused during minimally invasive procedures. Tissue engaging member 140 is separate from access port 110 and adapter 330, and may be inserted into a tissue incision site prior to, or in conjunction with, the introduction of access port 110 and adapter 330. Tissue engaging member 140 is formed of a material suitable for contact with internal body surfaces. Further, the surface of tissue engaging member 140 that is in contact with adapter 330 may be designed to provide an enhanced frictional engagement to secure adapter 330 and access port 110 in place, or may be lubricous so as to ease insertion of the adapter 330 and access port 110 into a layer of tissue 600.
In use, the operator of the surgical access assembly 300 will place tissue engaging member 140 in a layer of tissue 600 such that it protects the tissue walls from damage. The proximal edge 140a of tissue engaging member 140 may then be rolled to adjust the length of tissue engaging member 140 or to retract a tissue wall 600. The operator of the surgical access assembly 300 will then insert access port 110 into adapter 330, and insert them in a layer of tissue 600 such that the outer surface of the adapter 330 engages the tissue engaging member 140. Tissue engaging member 140 and adapter 330 are sized to create a substantially fluid tight seal, and further to secure access port 110 and adapter 330 into a layer of tissue 600. Alternatively, access port 110 may be pre-assembled with adapter 330. Tissue engaging member 140 may also be inserted in conjunction with access port 110 and adapter 330. Minimally invasive procedures can then be performed through the surgical access assembly 300 as described above with respect to surgical access assembly 100.
Turning to
Surgical access assembly 400 includes an adapter 430 that has a proximal end 430a, a distal end 430b, and a passage therethrough for the receipt of access port 110. Adapter 430 sealably engages access port 110 so as to minimize the escape of insufflation gases from the internal body cavity 600b below surgical access assembly 400. As in previous embodiments, distal end 430b of adapter 430 includes an internal recess 434b that engages a flange 112b at the distal end 110b of access port 110. Access port 110 is thus securely anchored in adapter 430.
At a proximal end 430a of adapter 430, the edges of adapter 430 are curled away from the access port 110, and are rolled toward a body surface 600a. Thus, proximal end 430a of adapter 430 is defined by the rolled edge of adapter 430. This may serve to act as a flange as in previous embodiments to anchor surgical access assembly 400 to the layer of tissue 600. The extent to which the edge at the proximal end 430a of adapter 430 is rolled necessarily shortens the length of adapter 430 that is disposed around the body of access port 110. Thus, the operator of the surgical access assembly 400 has the control to change the axial length of the adapter 430.
In use, the operator of the surgical access assembly 400 will insert the tissue engaging member 140 into a layer of tissue 600. The proximal edge 140a of tissue engaging member 140 may then be rolled to adjust the length of tissue engaging member 140 or to retract a tissue wall 600. The operator will then insert the access port 110 into adapter 430. Proximal end 430a of adapter 430 will extend proximally above the access port 110. The operator of the surgical access assembly 400 will curl the proximal end 430a of the adapter 430 away from the access port 110 and roll it toward a body surface 600a to a desired degree. Alternatively, the distal end 430a of the adapter 430 may be rolled after insertion into the tissue engaging member 140 and the layer of tissue 600. Insertion of the access port 110 and the adapter 430 into the tissue engaging member 140 proceeds as described above with respect to surgical access assembly 300. Alternatively, tissue engaging member 140 may be inserted into a tissue layer 600 in conjunction with access port 110 and adapter 430. Minimally invasive procedures can then be performed in a manner described above.
Referring to
Surgical access assembly 500 includes an adapter 530 having a proximal end 530a and a distal end 530b, and having a passage therethrough for the receipt of access port 110. Adapter has a gap 530c in its circumference. Adapter 530, upon expansion due to stresses from an object inserted therethrough, biases gap 530c toward a closed position. Thus, when access port 110 is inserted into adapter 530, adapter 530 biases the gap 530c toward a closed position such that adapter 530 is securely engaged around access port 110. The pressed engagement of the access port 110 and adapter 530 in a layer of tissue 600 forms a substantially fluid-tight seal and minimizes the escape of insufflation gases from an internal body cavity 600b below surgical access assembly 500.
In use, an operator of a surgical access assembly 500 inserts the tissue engaging member 140 into a layer of tissue 600. The proximal edge 140a of tissue engaging member 140 may then be rolled to adjust the length of tissue engaging member 140 or to retract a tissue wall 600. The operator will then insert access port 110 into adapter 530. Alternatively, adapter 530 may be wrapped around the outer circumference of access port 110 by widening the gap 530c during placement. With the access port 110 disposed within adapter 530, and adapter 530 expanded in response, adapter 530 tends to bias the gap 530c toward a closed position, thus securing access port 110 in place. Insertion of the surgical access port 110 and adapter 530 into the tissue engaging member 140 and performing minimally invasive procedures proceeds in a manner described above with respect to the previous embodiments. Alternatively, tissue engaging member 140 may be inserted into a layer of tissue 600 in conjunction with surgical access port 110 and adapter 530.
Turning to
It will be understood that various modifications may be made to the embodiments disclosed herein. Therefore, the above description should not be construed as limiting, but merely as exemplifications of embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the present disclosure.
The present application claims the benefit of and priority to U.S. Provisional Application Ser. No. 61/466,562, filed on Mar. 23, 2011, the entire contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
5366478 | Brinkerhoff et al. | Nov 1994 | A |
5524644 | Crook | Jun 1996 | A |
5549637 | Crainich | Aug 1996 | A |
5553675 | Pitzen et al. | Sep 1996 | A |
5564615 | Bishop et al. | Oct 1996 | A |
5609560 | Ichikawa et al. | Mar 1997 | A |
5634937 | Mollenauer et al. | Jun 1997 | A |
5735791 | Alexander, Jr. et al. | Apr 1998 | A |
6033426 | Kaji | Mar 2000 | A |
6033428 | Sardella | Mar 2000 | A |
6077288 | Shimomura et al. | Jun 2000 | A |
6165169 | Panescu et al. | Dec 2000 | A |
6254534 | Butler et al. | Jul 2001 | B1 |
6382211 | Crook | May 2002 | B1 |
6440063 | Beane et al. | Aug 2002 | B1 |
6450983 | Rambo | Sep 2002 | B1 |
6558371 | Dorn | May 2003 | B2 |
6582364 | Butler et al. | Jun 2003 | B2 |
6743240 | Smith et al. | Jun 2004 | B2 |
6958037 | Ewers et al. | Oct 2005 | B2 |
6972026 | Caldwell et al. | Dec 2005 | B1 |
7033319 | Pulford et al. | Apr 2006 | B2 |
7163510 | Kahle et al. | Jan 2007 | B2 |
7195590 | Butler et al. | Mar 2007 | B2 |
7445597 | Butler et al. | Nov 2008 | B2 |
7575144 | Ortiz et al. | Aug 2009 | B2 |
7588175 | Timm et al. | Sep 2009 | B2 |
7704207 | Albrecht et al. | Apr 2010 | B2 |
7721931 | Shelton, IV et al. | May 2010 | B2 |
7727146 | Albrecht et al. | Jun 2010 | B2 |
7738971 | Swayze et al. | Jun 2010 | B2 |
7803151 | Whitman | Sep 2010 | B2 |
7922061 | Shelton, IV et al. | Apr 2011 | B2 |
8035487 | Malackowski | Oct 2011 | B2 |
8231527 | Beckman et al. | Jul 2012 | B2 |
8282546 | Shelton et al. | Oct 2012 | B2 |
8323184 | Spiegal et al. | Dec 2012 | B2 |
8348855 | Hillely et al. | Jan 2013 | B2 |
8758391 | Swayze et al. | Jun 2014 | B2 |
8806973 | Ross et al. | Aug 2014 | B2 |
8875972 | Weisenburgh, II et al. | Nov 2014 | B2 |
8893946 | Boudreaux et al. | Nov 2014 | B2 |
8899462 | Kostrzewski et al. | Dec 2014 | B2 |
8939344 | Olson et al. | Jan 2015 | B2 |
8960519 | Whitman et al. | Feb 2015 | B2 |
8961396 | Azarbarzin et al. | Feb 2015 | B2 |
8968276 | Zemlok et al. | Mar 2015 | B2 |
8968337 | Whitfield et al. | Mar 2015 | B2 |
8992422 | Spivey et al. | Mar 2015 | B2 |
9064653 | Prest et al. | Jun 2015 | B2 |
9113875 | Viola et al. | Aug 2015 | B2 |
9216013 | Scirica et al. | Dec 2015 | B2 |
9282961 | Whitman et al. | Mar 2016 | B2 |
9282963 | Bryant | Mar 2016 | B2 |
9295522 | Kostrzewski | Mar 2016 | B2 |
9307986 | Hall et al. | Apr 2016 | B2 |
20010037053 | Bonadio et al. | Nov 2001 | A1 |
20020049454 | Whitman et al. | Apr 2002 | A1 |
20020165541 | Whitman | Nov 2002 | A1 |
20030014076 | Mollenauer et al. | Jan 2003 | A1 |
20030165794 | Matoba | Sep 2003 | A1 |
20040002632 | D'Arrigo et al. | Jan 2004 | A1 |
20050288558 | Ewers et al. | Dec 2005 | A1 |
20060142740 | Sherman et al. | Jun 2006 | A1 |
20060161050 | Butler et al. | Jul 2006 | A1 |
20060247678 | Weisenburgh, II et al. | Nov 2006 | A1 |
20070023476 | Whitman et al. | Feb 2007 | A1 |
20080021359 | Beckman et al. | Jan 2008 | A1 |
20080021362 | Fihe et al. | Jan 2008 | A1 |
20080167736 | Swayze et al. | Jul 2008 | A1 |
20080237296 | Boudreaux et al. | Oct 2008 | A1 |
20080308603 | Shelton et al. | Dec 2008 | A1 |
20090090763 | Zemlok et al. | Apr 2009 | A1 |
20090093752 | Richard et al. | Apr 2009 | A1 |
20090326330 | Bonadio et al. | Dec 2009 | A1 |
20100041957 | Urano et al. | Feb 2010 | A1 |
20100094094 | DeSantis et al. | Apr 2010 | A1 |
20100130825 | Piskun | May 2010 | A1 |
20100130826 | Piskun | May 2010 | A1 |
20100137691 | Piskun | Jun 2010 | A1 |
20100193568 | Scheib et al. | Aug 2010 | A1 |
20100211053 | Ross et al. | Aug 2010 | A1 |
20100240960 | Richard | Sep 2010 | A1 |
20100249516 | Shelton et al. | Sep 2010 | A1 |
20100249520 | Shelton et al. | Sep 2010 | A1 |
20100249521 | Shelton et al. | Sep 2010 | A1 |
20100249523 | Spiegal et al. | Sep 2010 | A1 |
20100249524 | Ransden et al. | Sep 2010 | A1 |
20100249527 | Brustad et al. | Sep 2010 | A1 |
20100261970 | Shelton et al. | Oct 2010 | A1 |
20100280326 | Hess et al. | Nov 2010 | A1 |
20100280327 | Nobis et al. | Nov 2010 | A1 |
20100286483 | Bettuchi et al. | Nov 2010 | A1 |
20100286484 | Stellon et al. | Nov 2010 | A1 |
20100298646 | Stellon et al. | Nov 2010 | A1 |
20100312061 | Hess et al. | Dec 2010 | A1 |
20100312064 | Weisenburgh et al. | Dec 2010 | A1 |
20100312066 | Cropper et al. | Dec 2010 | A1 |
20110009703 | Smith | Jan 2011 | A1 |
20110009704 | Marczyk et al. | Jan 2011 | A1 |
20110021877 | Fortier et al. | Jan 2011 | A1 |
20110021879 | Hart et al. | Jan 2011 | A1 |
20110028891 | Okoniewski | Feb 2011 | A1 |
20110034778 | Kleyman | Feb 2011 | A1 |
20110054257 | Stopek | Mar 2011 | A1 |
20110054258 | O'Keefe et al. | Mar 2011 | A1 |
20110066001 | Shelton et al. | Mar 2011 | A1 |
20110071508 | Duval et al. | Mar 2011 | A1 |
20110082341 | Kleyman et al. | Apr 2011 | A1 |
20110082343 | Okoniewski | Apr 2011 | A1 |
20110082346 | Stopek | Apr 2011 | A1 |
20110112374 | Brustad et al. | May 2011 | A1 |
20110118552 | Fischvogt | May 2011 | A1 |
20110118553 | Stopek | May 2011 | A1 |
20110124967 | Morgan et al. | May 2011 | A1 |
20110124968 | Kleyman | May 2011 | A1 |
20110124970 | Kleyman | May 2011 | A1 |
20110144444 | Sakai et al. | Jun 2011 | A1 |
20110155786 | Shelton, IV | Jun 2011 | A1 |
20110166423 | Farascioni et al. | Jul 2011 | A1 |
20110172648 | Jeong | Jul 2011 | A1 |
20110174099 | Ross et al. | Jul 2011 | A1 |
20110196302 | Gildersleeve et al. | Aug 2011 | A1 |
20110201893 | O'Prey et al. | Aug 2011 | A1 |
20110251463 | Kleyman | Oct 2011 | A1 |
20110251464 | Kleyman | Oct 2011 | A1 |
20110251465 | Kleyman | Oct 2011 | A1 |
20110251466 | Kleyman et al. | Oct 2011 | A1 |
20110276057 | Conlon et al. | Nov 2011 | A1 |
20110295074 | Stefanchik et al. | Dec 2011 | A1 |
20110295077 | Stefanchik et al. | Dec 2011 | A1 |
20120074199 | Olson et al. | Mar 2012 | A1 |
20120083660 | Okoniewski | Apr 2012 | A1 |
20120083661 | Rockrohr | Apr 2012 | A1 |
20120089131 | Zemlok et al. | Apr 2012 | A1 |
20120104071 | Bryant | May 2012 | A1 |
20120116368 | Viola | May 2012 | A1 |
20120130177 | Davis | May 2012 | A1 |
20120130179 | Rockrohr | May 2012 | A1 |
20120130181 | Davis | May 2012 | A1 |
20120130182 | Rodrigues et al. | May 2012 | A1 |
20120130183 | Barnes | May 2012 | A1 |
20120130184 | Richard | May 2012 | A1 |
20120130185 | Pribanic | May 2012 | A1 |
20120130186 | Stopek et al. | May 2012 | A1 |
20120130187 | Okoniewski | May 2012 | A1 |
20120130188 | Okoniewski | May 2012 | A1 |
20120130189 | Kleyman | May 2012 | A1 |
20120130190 | Kasvikis | May 2012 | A1 |
20120130191 | Pribanic | May 2012 | A1 |
20120143007 | Haig et al. | Jun 2012 | A1 |
20120149987 | Richard et al. | Jun 2012 | A1 |
20120157779 | Fischvogt | Jun 2012 | A1 |
20120157780 | Okoniewski et al. | Jun 2012 | A1 |
20120157781 | Kleyman | Jun 2012 | A1 |
20120157782 | Alfieri | Jun 2012 | A1 |
20120157784 | Kleyman et al. | Jun 2012 | A1 |
20120157786 | Pribanic | Jun 2012 | A1 |
20120165611 | Warren et al. | Jun 2012 | A1 |
20120190931 | Stopek | Jul 2012 | A1 |
20120190932 | Okoniewski | Jul 2012 | A1 |
20120190933 | Kleyman | Jul 2012 | A1 |
20120209077 | Racenet | Aug 2012 | A1 |
20120209078 | Pribanic et al. | Aug 2012 | A1 |
20120238825 | Smith | Sep 2012 | A1 |
20120245423 | Rodrigues | Sep 2012 | A1 |
20120245425 | Okoniewski | Sep 2012 | A1 |
20120245427 | Kleyman | Sep 2012 | A1 |
20120245428 | Smith et al. | Sep 2012 | A1 |
20120245429 | Smith | Sep 2012 | A1 |
20120245430 | Kleyman et al. | Sep 2012 | A1 |
20120253134 | Smith | Oct 2012 | A1 |
20120253136 | Rodrigues, Jr. | Oct 2012 | A1 |
20120283520 | Kleyman | Nov 2012 | A1 |
20120289785 | Albrecht et al. | Nov 2012 | A1 |
20120330285 | Hartoumbekis et al. | Dec 2012 | A1 |
20130093149 | Saur et al. | Apr 2013 | A1 |
20130181035 | Milliman | Jul 2013 | A1 |
20130184704 | Beardsley et al. | Jul 2013 | A1 |
20130274722 | Kostrzewski et al. | Oct 2013 | A1 |
20130324978 | Nicholas et al. | Dec 2013 | A1 |
20130324979 | Nicholas et al. | Dec 2013 | A1 |
20130334281 | Williams | Dec 2013 | A1 |
20140207125 | Applegate et al. | Jul 2014 | A1 |
20140373652 | Zergiebel et al. | Dec 2014 | A1 |
20150157321 | Zergiebel et al. | Jun 2015 | A1 |
20150164502 | Richard et al. | Jun 2015 | A1 |
20150272577 | Zemlok et al. | Oct 2015 | A1 |
20150297199 | Nicholas et al. | Oct 2015 | A1 |
20150303996 | Calderoni | Oct 2015 | A1 |
20150320420 | Penna et al. | Nov 2015 | A1 |
20150327850 | Kostrzewski | Nov 2015 | A1 |
20150342601 | Williams et al. | Dec 2015 | A1 |
20150342603 | Zergiebel et al. | Dec 2015 | A1 |
20150374366 | Zergiebel et al. | Dec 2015 | A1 |
20150374370 | Zergiebel et al. | Dec 2015 | A1 |
20150374371 | Richard et al. | Dec 2015 | A1 |
20150374372 | Zergiebel et al. | Dec 2015 | A1 |
20150374449 | Chowaniec et al. | Dec 2015 | A1 |
20150380187 | Zergiebel et al. | Dec 2015 | A1 |
20160095585 | Zergiebel et al. | Apr 2016 | A1 |
20160095596 | Scirica et al. | Apr 2016 | A1 |
20160106406 | Cabrera et al. | Apr 2016 | A1 |
20160113648 | Zergiebel et al. | Apr 2016 | A1 |
20160113649 | Zergiebel et al. | Apr 2016 | A1 |
Number | Date | Country |
---|---|---|
0950376 | Oct 1999 | EP |
2229900 | Sep 2010 | EP |
2289438 | Mar 2011 | EP |
2668910 | Dec 2013 | EP |
20120022521 | Mar 2012 | KR |
2006040748 | Apr 2006 | WO |
WO2006115893 | Nov 2006 | WO |
WO2008011358 | Jan 2008 | WO |
Entry |
---|
European Search Report for corresponding EP12160727 date of mailing is Jun. 15, 2012 (8 pgs). |
Extended European Search Report corresponding to International Application No. EP 15 15 1076.5 dated Apr. 22, 2015. |
Japanese Office Action corresponding to International Application No. JP 2011-084092 dated Jan. 14, 2016. |
Extended European Search Report corresponding to International Application No. EP 12 19 7970.2 dated Jan. 28, 2016. |
Chinese Office Action corresponding to International Application No. CN 201210560638.1 dated Oct. 21, 2015. |
European Office Action corresponding to International Application No. EP 14 15 9056.2 dated Oct. 26, 2015. |
Australian Examination Report No. 1 corresponding to International Application No. AU 2015200153 dated Dec. 11, 2015. |
Australian Examination Report No. 1 corresponding to International Application No. AU 2014204542 dated Jan. 7, 2016. |
Chinese Office Action corresponding to International Application No. CN 201310125449.6 dated Feb. 3, 2016. |
Extended European Search Report corresponding to International Application No. EP 15 19 0245.9 dated Jan. 28, 2016. |
Extended European Search Report corresponding to International Application No. EP 15 16 7793.7 dated Apr. 5, 2016. |
European Office Action corresponding to International Application No. EP 14 18 4882.0 dated Apr. 25, 2016. |
Extended European Search Report corresponding to International Application No. EP 14 19 6704.2 dated Sep. 24, 2015. |
International Search Report and Written Opinion corresponding to Int'l Appln. No. PCT/US2015/051837, mailed Dec. 21, 2015. |
Extended European Search Report corresponding to International Application No. EP 14 19 7563.1 dated Aug. 5, 2015. |
Partial European Search Report corresponding to International Application No. EP 15 19 0643.5 dated Feb. 26, 2016. |
Extended European Search Report corresponding to International Application No. EP 15 16 6899.3 dated Feb. 3, 2016. |
Extended European Search Report corresponding to International Application No. EP 14 19 9783.3 dated Dec. 22, 2015. |
Extended European Search Report corresponding to International Application No. EP 15 17 3807.7 dated Nov. 24, 2015. |
Extended European Search Report corresponding to International Application No. EP 15 19 0760.7 dated Apr. 1, 2016. |
Extended European Search Report corresponding to International Application No. EP 15 17 3803.6 dated Nov. 24, 2015. |
Extended European Search Report corresponding to International Application No. EP 15 17 3804.4 dated Nov. 24, 2015. |
Extended European Search Report corresponding to International Application No. EP 15 18 8539.9 dated Feb. 17, 2016. |
Extended European Search Report corresponding to International Application No. EP 15 17 3910.9 dated Nov. 13, 2015. |
European Office Action corresponding to International Application No. EP 14 15 2236.7 dated Aug. 11, 2015. |
Extended European Search Report corresponding to International Application No. EP 15 18 4915.5 dated Jan. 5, 2016. |
Number | Date | Country | |
---|---|---|---|
20120245428 A1 | Sep 2012 | US |
Number | Date | Country | |
---|---|---|---|
61466562 | Mar 2011 | US |